Doctor profile · Federal record
Dr. Srikanth Naramala, M.D
Rheumatology Physician (CMS: Rheumatology) · Internal Medicine Physician · Visalia, CA
- NPI 1437412129
- MIPS 36.0 / 100 · 2023
- 18 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
220 S Akers St Ste D
Visalia, CA 932915185
(559) 732-1648
fax (559) 636-0519
Credentials & registration
- NPI registered
- June 2012 — 14 yrs on file
- Profile last updated
- October 8, 2025
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (2)
- California #A1455595 · California #A145595
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1437412129. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
254,383
Distinct HCPCS
10
Medicare allowed
$3,506,014
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 83,238 | 23 | $6 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 73,105 | 72 | $10 | |
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 27,206 | 11 | $5 | |
J0897 |
Injection, denosumab, 1 mg | 26,080 | 278 | $23 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 20,100 | 25 | $13 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 9,855 | 46 | $33 | |
J9312 |
Injection, rituximab, 10 mg | 4,911 | 30 | $80 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 2,318 | 1,149 | $129 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,867 | 274 | $1 | |
96372 |
Injection of drug or substance under skin or into muscle | 1,196 | 447 | $15 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 7,481. This provider delivers 34× the peer median.Open Payments
Industry payments received
All-time total
$2,331
Transactions
125
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 36 | $627.47 | |
| Amgen Inc. | 19 | $305.10 | |
| Janssen Biotech, Inc. | 14 | $238.10 | |
| PFIZER INC. | 10 | $158.21 | |
| GlaxoSmithKline, LLC. | 9 | $150.94 | |
| Aurinia Pharma U.S., Inc. | 7 | $141.06 | |
| UCB, Inc. | 7 | $133.24 | |
| AstraZeneca Pharmaceuticals LP | 8 | $130.68 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $106.28 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $86.64 | |
| ANI Pharmaceuticals, Inc. | 3 | $75.01 | |
| Novartis Pharmaceuticals Corporation | 3 | $66.48 | |
| Alexion Pharmaceuticals, Inc. | 1 | $25.74 | |
| Genentech USA, Inc. | 1 | $23.68 | |
| Organon Llc | 1 | $22.43 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,408
Patients
1,304
Total drug cost
$1,653,216
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 538 | 190 | $20,393 |
| Hydroxychloroquine Sulfate | Generic | 470 | 143 | $25,581 |
| Prednisone | Generic | 438 | 168 | $4,154 |
| Gabapentin | Generic | 420 | 147 | $10,593 |
| Alendronate Sodium | Generic | 306 | 103 | $4,292 |
| Baclofen | Generic | 206 | 111 | $3,975 |
| Prolia (Denosumab) | Brand | 174 | 166 | $293,574 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 161 | 47 | $4,109 |
| Diclofenac Sodium | Generic | 141 | 60 | $4,774 |
| Cyclobenzaprine Hcl | Generic | 112 | 42 | $1,575 |
Hospital affiliations
Frequently asked questions
What is Dr. Srikanth Naramala's medical specialty?
Dr. Srikanth Naramala practices Rheumatology Physician in Visalia, CA.
Where does Dr. Srikanth Naramala practice?
Dr. Srikanth Naramala practices at 220 S Akers St Ste D, Visalia, CA 932915185. Office phone: 5597321648.
What is Dr. Srikanth Naramala's NPI?
Dr. Srikanth Naramala's National Provider Identifier (NPI) is 1437412129, issued by NPPES.
Does Dr. Srikanth Naramala accept Medicare assignment?
Dr. Srikanth Naramala does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Srikanth Naramala commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717). Source: CMS Medicare Physician & Other Practitioners file.